Atopic Dermatitis: A Review of Current Diagnostic Criteria and a Proposed Update to Management
March 2020 | Volume 19 | Issue 3 | Original Article | 244 | Copyright © March 2020
Published online February 4, 2020
Matthew Reynolds , Joe Gorelick , Matthew Bruno
aArkansas Dermatology and Skin Cancer Center, Little Rock, AR bCalifornia Skin Institute, San Jose, CA cDermatology and Skin Cancer Surgery Center, Allen, TX
The diagnosis of atopic dermatitis (AD) remains primarily a clinical diagnosis, in which several clinical signs and symptoms including pruritus, the presence and location of skin lesions, and a personal or family history of atopic conditions are used to facilitate a diagnosis. In recent decades, several well-established sets of criteria have been developed to aid diagnosis. With increased awareness of AD and the recent development of systemic immunomodulators to treat the condition, there exists a need to further define and consolidate the current diagnostic criteria while refining our current understanding of the clinical features of AD. We propose a novel, simplified set of criteria that comprises the clinical features generally considered to be essential for a confirmed diagnosis of AD, together with features previously regarded as having less clinical significance. It is essential, however, that any refinements to the diagnostic criteria for AD are made alongside regular updates of treatment guidelines so that these also reflect current developments. In this regard, the current guidelines in the United States are lacking and should be updated.
J Drugs Dermatol. 2020;19(3): doi:10.36849/JDD.2020.4737
THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE.
PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN.
NO PURCHASE NECESSARY.
PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.
Atopic dermatitis (AD) is a common and chronic inflammatory skin disease characterized by intense pruritis, recurrent eczematous lesions, xerosis, and lichenification. 1,2 Although primarily recognized as a childhood disorder, starting in infancy and affecting up to 20% of children, AD is also prevalent in adults. Some adults may develop new-onset AD, while others may have recurrence of childhood AD symptoms that had shown remission. Using the strictest diagnostic criteria (age of onset <2 years old), a recent study indicated that the prevalence of AD among adults in the United States (US) is 7.3%.3 In another study it was found that approximately 25% of adults with AD in the US have severe disease.4
Several sets of diagnostic criteria for AD have been described in recent decades; none are used universally, and each varies in the diagnostic features given prominence, thus precluding comparability between epidemiological studies.
The objective of this review is to describe the current thinking on the clinical features of AD alongside current treatment guidelines, in order to consolidate and distill past and current criteria used in AD diagnosis, and thereby propose a more simplified set of diagnostic criteria.
Clinical Features and the Diagnosis of AD
In the absence of a definitive laboratory test, a diagnosis of AD is made based on the presence and distribution pattern of lesions with specific morphologic features, associated clinical findings, and a personal or family history of atopy. Clinical features typically present are listed in Table 1.5
Many of the more recently described clinical features of AD such as baseline ocular features, periorbital dermatitis, and prurigo/ prurigo nodularis2,6,7 are now considered to hold greater clinical significance than previously assumed yet are lacking in older criteria that are still in routine use.
Further complicating a confirmed diagnosis of AD with a given set of criteria is the fact that several of the clinical features used in diagnosis are heterogeneous in nature, varying by global region and age.2 Furthermore, phenotypic differences exist between adult- and childhood-onset AD; for example, a US study suggests that those with adult-onset AD are more likely to have been born outside of the US, have less atopy, and a predilection for hand, head, and neck rash than children with AD.7 Such phenotypic differences should be considered in both diagnosis and when assessing disease severity.2
Current and Past Diagnostic Criteria
The most widely used and recognized criteria for the diagnosis of AD are the Hanifin–Rajka criteria, introduced in 1980,8 which remain one of the primary criteria used in the hospital setting today. This model mandates that at least 3 of 4 major